The Cardiovascular Outcome Study ( COS ) was an ancillary study of the Age-Related Eye Disease Study 2 ( AREDS2 ) , a factorial-designed randomized clinical trial of 4203 participants recruited from 82 US academic and community ophthalmology clinics , who were followed up for a median of 4.8 years .